ATE336513T1 - Antikörper, die spezifisch für freies inaktives psa sind, und ihre verwendungen - Google Patents

Antikörper, die spezifisch für freies inaktives psa sind, und ihre verwendungen

Info

Publication number
ATE336513T1
ATE336513T1 AT01923782T AT01923782T ATE336513T1 AT E336513 T1 ATE336513 T1 AT E336513T1 AT 01923782 T AT01923782 T AT 01923782T AT 01923782 T AT01923782 T AT 01923782T AT E336513 T1 ATE336513 T1 AT E336513T1
Authority
AT
Austria
Prior art keywords
antibody
antibodies specific
zymogen
inactive
free psa
Prior art date
Application number
AT01923782T
Other languages
English (en)
Inventor
Jean-Philippe Charrier
Colette Jolivet-Reynaud
Sandrine Michel
Original Assignee
Bio Merieux
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Merieux filed Critical Bio Merieux
Application granted granted Critical
Publication of ATE336513T1 publication Critical patent/ATE336513T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069Reproductive system, e.g. ovaria, uterus, testes, prostate
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57434Specifically defined cancers of prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Food Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT01923782T 2000-04-10 2001-04-10 Antikörper, die spezifisch für freies inaktives psa sind, und ihre verwendungen ATE336513T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0004591A FR2807438B1 (fr) 2000-04-10 2000-04-10 Nouveaux anticorps reconnaissant specifiquement le psa libre inactif, et leurs applications

Publications (1)

Publication Number Publication Date
ATE336513T1 true ATE336513T1 (de) 2006-09-15

Family

ID=8849094

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01923782T ATE336513T1 (de) 2000-04-10 2001-04-10 Antikörper, die spezifisch für freies inaktives psa sind, und ihre verwendungen

Country Status (10)

Country Link
US (2) US20030153017A1 (de)
EP (1) EP1272525B1 (de)
AT (1) ATE336513T1 (de)
AU (1) AU2001250470A1 (de)
CA (1) CA2405637A1 (de)
DE (1) DE60122306T2 (de)
ES (1) ES2269376T3 (de)
FR (1) FR2807438B1 (de)
PT (1) PT1272525E (de)
WO (1) WO2001077180A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0325483D0 (en) * 2003-10-31 2003-12-03 Plasmacute As Assay
US20070254317A1 (en) * 2004-03-03 2007-11-01 Biomerieux Method for Detecting the Activatable Free Form of Psa and the Use Thereof for Diagnosing Benign Pathologies of the Prostate and Adenocarcinoma of the Prostate
DE102007028659A1 (de) * 2007-06-21 2008-12-24 Siemens Ag Diagnosesubstanz und Verfahren zur Diagnose von Prostataerkrankungen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002480D0 (sv) * 1990-07-23 1990-07-23 Hans Lilja Assay of free and complexed prostate-specific antigen
EP0635575A1 (de) * 1993-07-22 1995-01-25 Wallac Oy Monoklonale Antikörper gegen Epitope in freiem uber nicht in Alpha-1-antichymotrypsin komplexiertem Prostata spezifisches Antigen
CA2286090C (en) * 1997-04-30 2013-01-08 Hybritech Incorporated Forms of prostate specific antigen and methods for their detection
US5994085A (en) * 1997-08-26 1999-11-30 Cantor; Thomas L. Methods and devices for detecting non-complexed prostate specific antigen
FR2780791B1 (fr) * 1998-07-03 2000-09-01 Bio Merieux Methode de depistage ou de diagnostic d'un adenocarcinome ou d'une pathologie benigne de la prostate et procede de mise en oeuvre
US6482599B1 (en) * 1999-04-30 2002-11-19 Hybritech Incorporated Forms of prostate specific antigen (PSA) specific for benign prostatic hyperplasia (BPH) and methods of using such

Also Published As

Publication number Publication date
US20070020710A1 (en) 2007-01-25
ES2269376T3 (es) 2007-04-01
EP1272525A1 (de) 2003-01-08
DE60122306T2 (de) 2007-08-30
CA2405637A1 (fr) 2001-10-18
FR2807438A1 (fr) 2001-10-12
WO2001077180A1 (fr) 2001-10-18
PT1272525E (pt) 2006-12-29
EP1272525B1 (de) 2006-08-16
AU2001250470A1 (en) 2001-10-23
DE60122306D1 (de) 2006-09-28
FR2807438B1 (fr) 2004-09-17
US20030153017A1 (en) 2003-08-14

Similar Documents

Publication Publication Date Title
ATE432947T1 (de) Menschliche antikörper als detektionsreagenzien
MXPA05005288A (es) Inmunoanalisis no competitivo para analitos pequenos.
JP2004528574A5 (de)
ATE228247T1 (de) Testreagentien und testvorrichtungen
AU2002304640A1 (en) Method and diagnosis kit for selecting and or qualitative and/or quantitative detection of cells
DE602004024236D1 (en) Assay
SI1836500T1 (sl) Postopki in testi za razlikovanje med različnimioblikami bolezni in motenj ki so označene s trombocitopenijo in ali s spontano interakcijo med von Willebrandovim faktorjem vWF in krvnimi ploščicami
ATE274699T1 (de) Analytassay-vorrichtung mit vorabsorbieren-zone
DE69418284D1 (de) Vorrichtung zur analyse von haptenen und ihre verwendung
ATE310956T1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
EP1627038A4 (de) Biochipsysteme auf mikropartikelbasis und verwendungen davon
DE69615576D1 (de) Polyklonaler antikörper gegen tryptase und reinigungsverfahren zur verwendung in einem immunoassay für menschliche tryptase
WO2007076013A3 (en) Homocysteine immunoassay
DE60235011D1 (de) Assays für den präimplantationsfaktor und präimplantationsfaktorpeptide
ATE405837T1 (de) Festphase immunochromatographische testverfahren
RU2008130888A (ru) Мас-2вр как маркер для диагностики рака желудка
ATE405830T1 (de) Verfahren zur beseitigung von störungen in immunochromatographischen assays
ATE336513T1 (de) Antikörper, die spezifisch für freies inaktives psa sind, und ihre verwendungen
ATE282830T1 (de) Immuntest für human chromogranine a (cga), antikörper, reagenz und dazu geeigneter testsatz
CA2434694A1 (en) Detection and quantification of cripto-1
ATE259065T1 (de) Verfahren zum nachweis von helicobacter pylori und heilmanii
WO2006060188A3 (en) Anti-tenascin monoclonal antibody immunoassays and diagnostic kits
YU15401A (sh) Antitela visokog afiniteta
WO2006132809A3 (en) Monoclonal antibody reagents
ATE434185T1 (de) Immunoassay für h. pylori in fäkalienproben mit hilfe von gattungsspezifischen antikörpern

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties